Export Ready — 

Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis

<p>Abstract</p> <p>Background</p> <p>Type 2 diabetes is a risk factor for Alzheimer's disease (AD), most likely linked to an impairment of insulin signalling in the brain. Therefore, drugs that enhance insulin signalling may have therapeutic potential for AD. Lirag...

Full description

Saved in:
Bibliographic Details
Main Authors: Hunter Kerry, Hölscher Christian
Format: Artigo
Language:Inglês
Published: BMC 2012-03-01
Series:BMC Neuroscience
Subjects:
Alzheimer disease
Parkinson's disease
Diabetes
Neuroprotection
Stem cells
Online Access:http://www.biomedcentral.com/1471-2202/13/33
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items